lybalvi
(1R,9R,10S)-17-(cyclopropylmethyl)-3,10-dihydroxy-13-oxo-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide;2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine
Molecular Identity
lybalvi
(1R,9R,10S)-17-(cyclopropylmethyl)-3,10-dihydroxy-13-oxo-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide;2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine
PubChem CID: 136232822
2D Structure
Properties
C38H46N6O4S
Molecular Formula
682.90
Molecular Weight
g/mol
682.3301
Exact Mass
Da
163
TPSA
May have limited oral absorption
4
H-Bond Donors
9
H-Bond Acceptors
1100
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(10)
lybalviRefChem:66543olanzapine/samidorphan L-malateolanzapine;samidorphan L-malateOlanzapine; Samidorphan L-Malateolanzapine / samidorphan L-malateolanzapine and samidorphan L-malateOlanzapine/Samidorphanorb1738516GLXC-25407
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to lybalvi
Loading drug network...